The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Share News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: St Ives Dives After Profit Warning

Mon, 25th Apr 2016 09:38

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.
----------
FTSE 100 - WINNERS
----------
Imperial Brands, up 3.2%. The tobacco group was upgraded to Buy from Neutral by Goldman Sachs.
----------
FTSE 100 - LOSERS
----------
Oil companies, BP, down 2.4%, Royal Dutch Shell 'A', down 2.2%, Shell 'B', down 2.1%. The Brent crude price was lower Monday, trading at USD44.44 a barrel compared to USD45.56 at the London equities close on Friday.
----------
FTSE 250 - WINNERS
----------
Ted Baker, up 4.3%. Jefferies upgraded the fashion retailer to Buy from Hold.
----------
FTSE 250 - LOSERS
----------
Vedanta Resources, down 4.7%. Vedanta's Cairn India subsidiary late Friday said its fourth-quarter net loss widened year on year. Cairn India made a INR10,948 crore net loss in the three months ended March 31, widening from INR241 crore the corresponding quarter a year earlier. For the year ended March 31, Cairn India made a net loss of INR9,432 crore, versus a profit of INR4,480 crore a year earlier. Exceptional items for the year amounted to INR11,674 crore primarily on account of impairment of goodwill due to a significant decline in oil prices. Vedanta holds a 59.8% stake in Cairn India.
----------
Allied Minds, down 3.3%. The science and technology development group reported a widened pretax loss in what it called a "successful" 2015, as it increased investment in creating four new businesses and developing its existing businesses towards commercialisation. It reported a pretax loss of USD98.0 million for 2015, widened from USD57.7 million in 2014, mostly as a result of higher selling, general and administrative expenses, and a big step up in research and development costs. Allied Minds said its group subsidiary ownership adjusted value, a key metric for the company, rose to USD535.8 million as at the end of 2015 from USD488.0 million at the end of 2014.
----------
MAIN MARKET AND AIM - WINNERS
----------
Highlands Natural Resources, up 28%. The oil and gas explorer said it has made "significant progress" in commercialising its DT Ultravert technology, and said further acquisitions in America are in the works following its move in North Dakota last November. Last year the company bought a 75% interest in fracking technology DT Ultravert from Diversion Technologies. It said that, alongside Schlumberger NV, it is in ongoing talks with over 20 companies to commercialise DT Ultravert in the US. Highlands said it is evaluating a potential natural gas and associated helium play in the US, and it is currently in talks for joint development of mining claims it purchased in March covering 1,219 acres in Grand County, Utah.

Randall & Quilter Investments Holdings, up 15%. The non-life insurance investor said it swung to pretax profit in 2015 amid a good performance in its UK arm. Randall & Quilter said its pretax profit for the year to the end of December was GBP2.8 million, swung from a GBP1.6 million loss in 2014. The group had made a GBP4.5 million loss in the first half, but results improved significantly in the second half. The profit was driven by the group's run-off portfolios performing well in the second half, delivering a net reserve release of GBP9.5 million, compared to GBP2.4 million a year earlier.

Satellite Solutions Worldwide Group, up 7.5%. The satellite broadband provider said it has secured a GBP2.0 million unsecured loan note from the UK Business Growth Fund. The Business Growth Fund is backed by UK banks and provides funding for small and medium-sized businesses. The note carries a fixed coupon of 10% and is repayable after 12 months. The company said the funds will strengthen its balance sheet and allow the group to pursue acquisitions to drive growth.
----------
MAIN MARKET AND AIM - LOSERS
----------
St Ives, down 46%. The marketing services company said it expects its underling pretax profit for its current financial year to be "materially below" its current expectations, and warned the following year would also be hit. St Ives said its trading overall in the eight months to the beginning of April had continued to be "broadly in line" with its expectations, with revenue up 5% compared to the previous year, however its outlook for the final quarter to end-July and following financial year has deteriorated. Global economic uncertainty has led to significant projects being deferred or cancelled, the group said.

Outsourcery, down 38%. The cloud services company said 2016 trading is in line with its expectations, though this will include weaker revenue growth from its partners due to product launch delays. Outsourcery said it will require new short-term working capital and is investigating alternatives to raise money, including a fundraising, a restructuring and the disposal of non-core assets. The company said it is holding talks with its creditors on its financial position.

Immunodiagnostic Systems Holdings, down 16%. The immunodiagnostics testing company said it expects a significant asset write-down of goodwill and capitalised costs to be realised in the accounts for its most recently ended financial year, but said this will not hit its cashflow. The company reiterated expectations for a fall in revenue to GBP39 million for the year ended in March, down from GBP45 million the previous year, due to reductions in the company's manual assay business. The company also said it is continuing to lose business for its automated 25-OH Vitamin D assays as larger laboratories migrate to different systems once contracts are up for renewal. It expects these revenue trends to continue into its current financial year.
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
24 Oct 2016 08:30

Allied Minds raises £5m from Neil Woodford for prostate cancer technology

(ShareCast News) - Star UK fund manager Neil Woodford has bought £5m of new shares in Allied Minds subsidiary Precision Biopsy. Woodford Investment Management, which is already a substantial shareholder in FTSE 250-listed Allied Minds purchased 0.95m preference shares in Precision Biopsy. Having de

Read more
29 Sep 2016 08:12

Allied Minds partners with GE Ventures to commercialise emerging tech

(ShareCast News) - FTSE 250 intellectual property company Allied Minds partnered with General Electric's venture capital subsidiary to commercialise next generation technologies. Allied Minds and GE Ventures agreed to invest in new and existing technologies from each of their innovation pipelines.

Read more
25 Aug 2016 08:05

Allied Minds losses increase but focus remains on future potential

(ShareCast News) - Allied Minds, the university and government technology commercialisation specialist, reported an increased loss, smaller revenue and flat value of its investment assets over the first half of the year. However, the company remains more firmly focused on investing in its various as

Read more
22 Aug 2016 07:07

Allied Minds secures debt funding and raises funds for drug programme

(ShareCast News) - Venture capital-style investor Allied Minds has arranged a one-year debt facility Silicon Valley Bank in the US, while its drug discovery subsidiary has raised funds for its leading project from institutional investors. Secured over certain group assets, the $20m one-year facility

Read more
1 Aug 2016 08:12

Allied Minds investment SciFluor gets nod from FDA

(ShareCast News) - Life science and technology investor Allied Minds announced on Monday that one of its key subsidiaries, SciFluor Life Sciences, has achieved the necessary scientific and regulatory milestones to enter clinical trials. The FTSE 250 company said SciFluor's Investigational New Drug a

Read more
13 Jun 2016 16:35

DIRECTOR DEALINGS: Allied Minds COO Marc Eichenberger Sells Shares

Read more
27 May 2016 15:30

FTSE 250 movers: Phoenix Group firms on AXA Wealth deal

(ShareCast News) - FTSE 250 was marginally firmer in late afternoon trade as UK traders wound down ahead of a long weekend, with few of today's in-the-news mid-cap stocks figuring among that index's top-10 risers. Shares in Phoenix Group Holdings were ahead as it agreed with AXA UK to buy AXA Wealth

Read more
25 May 2016 10:04

Allied Minds announces successful completion of feasibility programme

(ShareCast News) - Allied Minds' partnership with Bristol-Myers Squibb (BMS), Allied-Bristol Life Sciences, has successfully completed the drug candidate feasibility programme ABLS II and has approved up to $15m to fund further development of the lead optimisation programme. ABLS II is seeking to de

Read more
25 May 2016 07:08

Allied Minds Approves USD15 Million Funding For Allied-Bristol

Read more
19 May 2016 15:03

AGM, EGM Calendar - Week Ahead

Read more
13 May 2016 11:42

DIRECTOR DEALINGS: Allied Minds COO Sells 49,242 Shares

Read more
26 Apr 2016 09:30

WINNERS & LOSERS SUMMARY: Cobham Crushed On Weak Profit, Rights Issue

Read more
26 Apr 2016 08:47

Allied Minds secures £55m funding for up to ten new drugs

(ShareCast News) - Science and technology development and commercialisation company Allied Minds announced a fresh $80m (£55m) of investment commitments on Tuesday, received through its newly-formed subsidiary ABLS Capital. The FTSE 250 firm said the funding would allow up to ten potential lead opti

Read more
26 Apr 2016 06:50

Allied Minds Secures USD80 Million Commitments For Drug Development

Read more
25 Apr 2016 14:07

FTSE 250 movers: Ted Baker boosted as strike threat hits Wood Group

(ShareCast News) - The FTSE 250 remained in the black in afternoon trading on Monday, though some stocks were under the pump as crude and copper prices fell. Ted Baker was one of the leading risers, after analysts at Jefferies upgraded the stock to 'buy' from 'hold', though they did cut the price ta

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.